Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Evaluation of Aliskiren Efficacy by Different Methods of Blood Pressure Measurements (REALITY)

This study has been terminated.
(The participants signed by mistake an old version of the informed consent. Their participation was annulated, and the study was stopped)
Sponsor:
Collaborator:
Novartis Pharmaceuticals
Information provided by (Responsible Party):
Meir Medical Center
ClinicalTrials.gov Identifier:
NCT01060865
First received: February 1, 2010
Last updated: May 5, 2013
Last verified: May 2011
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: December 2011
  Primary Completion Date: October 2011 (Final data collection date for primary outcome measure)